Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Vigneri

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Current Opinion in Oncology|October 14, 2014
The changing epidemiology of thyroid cancer: why is incidence increasing?Riccardo Vigneri, Pasqualino Malandrino, Paolo Vigneri
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2011
Cancer stem cells and chemosensitivityMarcello Maugeri-Saccà, Paolo Vigneri, Ruggero De Maria
Future Oncology (London, England)|December 8, 2015
Biomarkers and prognostic factors for malignant pleural mesotheliomaPaolo Vigneri, Federica Martorana, Livia Manzella, et al.
Translational Oncology|May 16, 2021
The other side of the coin: dissecting molecular mechanisms behind hereditary breast cancer in search of therapeutic opportunitiesStefania Stella, Federica Martorana, Livia Manzella, et al.
Plos One|February 25, 2011
Interplay between kinase domain autophosphorylation and F-actin binding domain in regulating imatinib sensitivity and nuclear import of BCR-ABLMartin Preyer, Paolo Vigneri, Jean Y J Wang
Expert Opinion on Drug Safety|June 20, 2020
Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitorVittorio Gebbia, Maria Rosaria Valerio, Alberto Firenze, et al.
Molecules (Basel, Switzerland)|December 10, 2021
A New Kid on the Block: Sacituzumab Govitecan for the Treatment of Breast Cancer and Other Solid TumorsGiuliana Pavone, Lucia Motta, Federica Martorana, et al.
Endocrine-Related Cancer|July 22, 2009
Diabetes and cancerPaolo Vigneri, Francesco Frasca, Laura Sciacca, et al.
International Journal of Molecular Sciences|November 21, 2018
Insulin Receptor Isoforms in CancerVeronica Vella, Agostino Milluzzo, Nunzio Massimo Scalisi, et al.
Cancers|July 15, 2026
Hermione Exchange Educational Program: How to Integrate Multidisciplinary Approaches to Manage HR+/HER2- Metastatic Breast CancerMarina Elena Cazzaniga, Nicola Fusco, Alessandra Fabi, et al.
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Current Opinion in Oncology|October 14, 2014
The changing epidemiology of thyroid cancer: why is incidence increasing?Riccardo Vigneri, Pasqualino Malandrino, Paolo Vigneri
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2011
Cancer stem cells and chemosensitivityMarcello Maugeri-Saccà, Paolo Vigneri, Ruggero De Maria
Future Oncology (London, England)|December 8, 2015
Biomarkers and prognostic factors for malignant pleural mesotheliomaPaolo Vigneri, Federica Martorana, Livia Manzella, et al.
Translational Oncology|May 16, 2021
The other side of the coin: dissecting molecular mechanisms behind hereditary breast cancer in search of therapeutic opportunitiesStefania Stella, Federica Martorana, Livia Manzella, et al.
Plos One|February 25, 2011
Interplay between kinase domain autophosphorylation and F-actin binding domain in regulating imatinib sensitivity and nuclear import of BCR-ABLMartin Preyer, Paolo Vigneri, Jean Y J Wang
Expert Opinion on Drug Safety|June 20, 2020
Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitorVittorio Gebbia, Maria Rosaria Valerio, Alberto Firenze, et al.
Molecules (Basel, Switzerland)|December 10, 2021
A New Kid on the Block: Sacituzumab Govitecan for the Treatment of Breast Cancer and Other Solid TumorsGiuliana Pavone, Lucia Motta, Federica Martorana, et al.
Endocrine-Related Cancer|July 22, 2009
Diabetes and cancerPaolo Vigneri, Francesco Frasca, Laura Sciacca, et al.
International Journal of Molecular Sciences|November 21, 2018
Insulin Receptor Isoforms in CancerVeronica Vella, Agostino Milluzzo, Nunzio Massimo Scalisi, et al.
Cancers|July 15, 2026
Hermione Exchange Educational Program: How to Integrate Multidisciplinary Approaches to Manage HR+/HER2- Metastatic Breast CancerMarina Elena Cazzaniga, Nicola Fusco, Alessandra Fabi, et al.
Pageof 15